← FDA Drug Approvals (Drugs@FDA)

CONJUPRI

NDA · New Drug Application · Sponsor: CSPC OUYI · Approved 2019-12-19

Drug application

FDA Application #

NDA212895

Application type

New Drug Application

Brand name

CONJUPRI

Generic name

LEVAMLODIPINE

Active ingredients

LEVAMLODIPINE MALEATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

CSPC OUYI

Manufacturer

CSPC Ouyi Pharmaceutical Co. Ltd

First approval

2019-12-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown